Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis (WBI-1001-201)
This study has been completed.
Sponsor:
Welichem Biotech Inc.
Information provided by:
Welichem Biotech Inc.
ClinicalTrials.gov Identifier:
NCT00837551
First received: February 3, 2009
Last updated: NA
Last verified: February 2009
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2008 |
| Primary Completion Date: | June 2008 (Final data collection date for primary outcome measure) |